Cargando…

Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer

INTRODUCTION: Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with a high risk of distant metastasis, an extremely poor prognosis, and a high risk of death. Regulatory T cells (Tregs) contribute to the formation of a tumor immunosuppressive microenvironment, whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Pengfei, Zhou, Xinyue, Zheng, Minying, Yu, Yongjun, Jin, Gongsheng, Zhang, Shiwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521732/ https://www.ncbi.nlm.nih.gov/pubmed/37767092 http://dx.doi.org/10.3389/fimmu.2023.1263537

Ejemplares similares

Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment
por: Zhang, Jinguo, et al.
Publicado: (2023)

Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
por: Zheng, Yiwen, et al.
Publicado: (2023)

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
por: Loizides, Sotiris, et al.
Publicado: (2023)

Vascular Microenvironment, Tumor Immunity and Immunotherapy
por: Lamplugh, Zachary, et al.
Publicado: (2021)

Immunotherapy: Reshape the Tumor Immune Microenvironment
por: LV, Bingzhe, et al.
Publicado: (2022)

Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer
por: Kudelova, Eva, et al.
Publicado: (2022)

Editorial: The immunosuppressive tumor microenvironment and strategies to revert its immune regulatory milieu for cancer immunotherapy
por: Ganjalikhani Hakemi, Mazdak, et al.
Publicado: (2023)

Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer
por: Qiu, Pengjun, et al.
Publicado: (2021)

The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer
por: Naik, Adviti, et al.
Publicado: (2019)

Editorial: Tumor microenvironment, immunotherapy, and drug resistance in breast and gastrointestinal cancer
por: Deng, Xinpei, et al.
Publicado: (2023)

Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer
por: Zhou, Qin, et al.
Publicado: (2023)

Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment
por: Scott, Ellen N., et al.
Publicado: (2021)

The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies
por: Xu, Jiuhui, et al.
Publicado: (2023)

Immunotherapy of targeting MDSCs in tumor microenvironment
por: Sui, Hongshu, et al.
Publicado: (2022)

A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer
por: Zhang, Juan, et al.
Publicado: (2023)

Enhanced Therapeutic Efficacy of Combining Losartan and Chemo-Immunotherapy for Triple Negative Breast Cancer
por: Zhao, Qing, et al.
Publicado: (2022)

Regulatory effects of IRF4 on immune cells in the tumor microenvironment
por: Lu, Jing, et al.
Publicado: (2023)

Evaluation of triple negative breast cancer with heterogeneous immune infiltration
por: Quintana, Ángela, et al.
Publicado: (2023)

Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression
por: Xing, Yingying, et al.
Publicado: (2021)

Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer
por: Tan, Abel H. Y., et al.
Publicado: (2019)

CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer
por: Cheng, Tianyi, et al.
Publicado: (2022)

T Regulatory Cells and Priming the Suppressive Tumor Microenvironment
por: Paluskievicz, Christina M., et al.
Publicado: (2019)

Effects of helicobacter pylori on tumor microenvironment and immunotherapy responses
por: Deng, Ruiyi, et al.
Publicado: (2022)

Integrating Genomic Information with Tumor-Immune Microenvironment in Triple-Negative Breast Cancer
por: Otohinoyi, David, et al.
Publicado: (2022)

Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy
por: Yang, Rou, et al.
Publicado: (2023)

The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer
por: Fan, Yiqi, et al.
Publicado: (2022)

Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
por: Albini, Adriana, et al.
Publicado: (2018)

Heterogeneity of tumor immune microenvironment and real-world analysis of immunotherapy efficacy in lung adenosquamous carcinoma
por: Li, Chao, et al.
Publicado: (2022)

Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy
por: Peng, Xin, et al.
Publicado: (2021)

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
por: Guo, Liting, et al.
Publicado: (2021)

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
por: Liu, Dan, et al.
Publicado: (2021)

Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy
por: Lin, Yi, et al.
Publicado: (2022)

Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
por: Zheng, Hongmei, et al.
Publicado: (2021)

Comprehensive Analysis of the Tumor Immune Microenvironment Landscape in Glioblastoma Reveals Tumor Heterogeneity and Implications for Prognosis and Immunotherapy
por: Zhao, Rongrong, et al.
Publicado: (2022)

Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment
por: Gandhi, Shipra, et al.
Publicado: (2021)

Classification of triple negative breast cancer by epithelial mesenchymal transition and the tumor immune microenvironment
por: Font-Clos, Francesc, et al.
Publicado: (2022)

Prognostic value of various immune cells and Immunoscore in triple-negative breast cancer
por: Ren, Xinyu, et al.
Publicado: (2023)

Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy
por: Zhang, Hongyan, et al.
Publicado: (2023)

92418 Molecular imaging of the tumor microenvironment to predict response to combination treatment with immunotherapy in triple negative breast cancer
por: Napier, Tiara S., et al.
Publicado: (2021)

Tumor Mutation Burden and Immune Invasion Characteristics in Triple Negative Breast Cancer: Genome High-Throughput Data Analysis
por: Gao, Chundi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lfo12r820rv80bhq8orqjpa55g